These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32449198)

  • 1. Alternative type 2 diabetes screening tests may reduce the number of U.S. adults with undiagnosed diabetes.
    Dadwani RS; Skandari MR; GoodSmith MS; Phillips LS; Rhee MK; Laiteerapong N
    Diabet Med; 2020 Nov; 37(11):1935-1943. PubMed ID: 32449198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined use of fasting plasma glucose and glycated hemoglobin A1c in the screening of diabetes and impaired glucose tolerance.
    Hu Y; Liu W; Chen Y; Zhang M; Wang L; Zhou H; Wu P; Teng X; Dong Y; Zhou Jw; Xu H; Zheng J; Li S; Tao T; Hu Y; Jia Y
    Acta Diabetol; 2010 Sep; 47(3):231-6. PubMed ID: 19760291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.
    Kuzuya T; Nakagawa S; Satoh J; Kanazawa Y; Iwamoto Y; Kobayashi M; Nanjo K; Sasaki A; Seino Y; Ito C; Shima K; Nonaka K; Kadowaki T;
    Diabetes Res Clin Pract; 2002 Jan; 55(1):65-85. PubMed ID: 11755481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time-saving screening for diabetes in patients with coronary artery disease: a report from EUROASPIRE IV.
    Gyberg V; De Bacquer D; Kotseva K; De Backer G; Schnell O; Tuomilehto J; Wood D; Rydén L
    BMJ Open; 2016 Dec; 6(12):e013835. PubMed ID: 27932342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HbA1c measurement improves the detection of type 2 diabetes in high-risk individuals with nondiagnostic levels of fasting plasma glucose: the Early Diabetes Intervention Program (EDIP).
    Perry RC; Shankar RR; Fineberg N; McGill J; Baron AD;
    Diabetes Care; 2001 Mar; 24(3):465-71. PubMed ID: 11289469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of Prediabetes and Undiagnosed Diabetes in Canada (2007-2011) According to Fasting Plasma Glucose and HbA1c Screening Criteria.
    Rosella LC; Lebenbaum M; Fitzpatrick T; Zuk A; Booth GL
    Diabetes Care; 2015 Jul; 38(7):1299-305. PubMed ID: 25852207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for diabetes with HbA1c: Test performance of HbA1c compared to fasting plasma glucose among Chinese, Malay and Indian community residents in Singapore.
    Lim WY; Ma S; Heng D; Tai ES; Khoo CM; Loh TP
    Sci Rep; 2018 Aug; 8(1):12419. PubMed ID: 30127499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fasting Plasma Glucose and the HbA1c Are Not Optimal Screening Modalities for the Diagnosis of New Diabetes in Previously Undiagnosed Asian Indian Community Participants.
    Prakaschandra R; Naidoo DP
    Ethn Dis; 2018; 28(1):19-24. PubMed ID: 29467562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using HbA(1c) to improve efficacy of the american diabetes association fasting plasma glucose criterion in screening for new type 2 diabetes in American Indians: the strong heart study.
    Wang W; Lee ET; Fabsitz R; Welty TK; Howard BV
    Diabetes Care; 2002 Aug; 25(8):1365-70. PubMed ID: 12145236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fasting plasma glucose in screening for NIDDM in the U.S. and Israel.
    Modan M; Harris MI
    Diabetes Care; 1994 May; 17(5):436-9. PubMed ID: 7741837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fasting glucose, HbA1c, or oral glucose tolerance testing for the detection of glucose abnormalities in patients with acute coronary syndromes.
    Hage C; Lundman P; Rydén L; Mellbin L
    Eur J Prev Cardiol; 2013 Aug; 20(4):549-54. PubMed ID: 22456695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive type 2 diabetes screening: superior sensitivity to fasting plasma glucose and A1C.
    Maynard JD; Rohrscheib M; Way JF; Nguyen CM; Ediger MN
    Diabetes Care; 2007 May; 30(5):1120-4. PubMed ID: 17337498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and Public Health Implications of 2019 Endocrine Society Guidelines for Diagnosis of Diabetes in Older Adults.
    Fang M; Echouffo-Tcheugui JB; Selvin E
    Diabetes Care; 2020 Jul; 43(7):1456-1461. PubMed ID: 32327419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy and cost of alternative strategies for systematic screening for type 2 diabetes in the U.S. population 45-74 years of age.
    Johnson SL; Tabaei BP; Herman WH
    Diabetes Care; 2005 Feb; 28(2):307-11. PubMed ID: 15677784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined use of a fasting plasma glucose concentration and HbA1c or fructosamine predicts the likelihood of having diabetes in high-risk subjects.
    Ko GT; Chan JC; Yeung VT; Chow CC; Tsang LW; Li JK; So WY; Wai HP; Cockram CS
    Diabetes Care; 1998 Aug; 21(8):1221-5. PubMed ID: 9702423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for dysglycaemia in patients with coronary artery disease as reflected by fasting glucose, oral glucose tolerance test, and HbA1c: a report from EUROASPIRE IV--a survey from the European Society of Cardiology.
    Gyberg V; De Bacquer D; Kotseva K; De Backer G; Schnell O; Sundvall J; Tuomilehto J; Wood D; Rydén L;
    Eur Heart J; 2015 May; 36(19):1171-7. PubMed ID: 25670820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for new-onset diabetes after kidney transplantation: limitations of fasting glucose and advantages of afternoon glucose and glycated hemoglobin.
    Yates CJ; Fourlanos S; Colman PG; Cohney SJ
    Transplantation; 2013 Oct; 96(8):726-31. PubMed ID: 23902993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost-effectiveness of testing strategies for type 2 diabetes: a modelling study.
    Gillett M; Brennan A; Watson P; Khunti K; Davies M; Mostafa S; Gray LJ
    Health Technol Assess; 2015 May; 19(33):1-80. PubMed ID: 25947106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening obese children and adolescents for prediabetes and/or type 2 diabetes in pediatric practices: a validation study.
    Brar PC; Mengwall L; Franklin BH; Fierman AH
    Clin Pediatr (Phila); 2014 Jul; 53(8):771-6. PubMed ID: 24671874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of HbA1c and OGTT for the diagnosis of type 2 diabetes in children at risk of diabetes.
    Kim MS; Jo DS; Lee DY
    Pediatr Neonatol; 2019 Aug; 60(4):428-434. PubMed ID: 30497969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.